Skip NavigationSkip to Content

IL-15 induces C4+ effector memory T cell production and tissue emigration in nonhuman primates

  1. Author:
    Picker, L. J.
    Reed-Inderbitzin, E. F.
    Hagen, S. I.
    Edgar, J. B.
    Hansen, S. G.
    Legasse, A.
    Planer, S.
    Piatak, M.
    Lifson, J. D.
    Maino, V. C.
    Axthelm, M. K.
    Villinger, F.
  2. Author Address

    Oregon Hlth Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA. Oregon Hlth Sci Univ, Dept Pathol, Beaverton, OR 97006 USA. Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA. Oregon Hlth Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA. SAIC Frederick Inc, NCI, AIDS Vaccine Program, Frederick, MD 21701 USA. BD Biosci, San Jose, CA USA. Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA Picker, LJ, Oregon Hlth Sci Univ, Vaccine & Gene Therapy Inst, W Campus,505 NW 185th Ave, Beaverton, OR 97006 USA
    1. Year: 2006
    2. Date: JUN
  1. Journal: Journal of Clinical Investigation
    1. 116
    2. 6
    3. Pages: 1514-1524
  2. Type of Article: Article
  1. Abstract:

    HIV infection selectively targets CD4(+) effector memory T (T-EM) cells, resulting in dramatic depletion of CD4(+) T cells in mucosal effector sites in early infection. Regeneration of the TEM cell compartment is slow and incomplete, even when viral replication is controlled by antiretroviral therapy (ART). Here, we demonstrate that IL-15 dramatically increases in vivo proliferation of rhesus macaque (RM) CD4(+) and CD8(+) TEM cells with little effect on the naive or central memory T (T-CM) cell subsets, a response pattern that is quite distinct from that of either IL-2 or IL-7. T-EM cells produced in response to IL-15 did not accumulate in blood. Rather, 5-bromo-2'-deoxyuridine (BrdU) labeling studies suggest that many of these cells rapidly disperse to extralymphoid effector sites, where they manifest (slow) decay kinetics indistinguishable from that of untreated controls. In RMs with uncontrolled SIV infection and highly activated immune systems, IL-15 did not significantly increase CD4(+) T-EM cell proliferation, but with virologic control and concomitant reduction in immune activation by ART, IL-15 responsiveness was again observed. These data suggest that therapeutic use of IL-15 in the setting of ART might facilitate specific restoration of the CD4(+) T cell compartment that is the primary target of HIV with less risk of exhausting precursor T cell compartments or generating potentially deleterious regulatory subsets

    See More

External Sources

  1. WOS: 000237979700014

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel